Hospital Ramón y Cajal -ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2023

  1. Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution

    Frontiers in Immunology, Vol. 14

2022

  1. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

2019

  1. Tendothelial extracellular vesicles produced by senescent cells: Pathophysiological role in the cardiovascular disease associated with all types of diabetes mellitus

    Current Vascular Pharmacology, Vol. 17, Núm. 5, pp. 447-454

2007

  1. Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in Von Hippel-Lindau patients

    Human Mutation, Vol. 28, Núm. 6, pp. 613-621

2005

  1. Brief report: Succinate dehydrogenase D variants do not constitute a risk factor for developing C cell hyperplasia or sporadic medullary thyroid carcinoma

    Journal of Clinical Endocrinology and Metabolism, Vol. 90, Núm. 4, pp. 2127-2130

2003

  1. VIP and PACAP receptors coupled to adenylyl cyclase in human lung cancer: A study in biopsy specimens

    Peptides, Vol. 24, Núm. 3, pp. 429-436

2002

  1. Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma

    European Journal of Human Genetics, Vol. 10, Núm. 8, pp. 457-461

2000

  1. Immunohistochemical and immunochemical evidence for expression of human lung PACAP/VIP receptors

    Annals of the New York Academy of Sciences

  2. Immunohistochemical localization and distribution of VIP/PACAP receptors in human lung

    Peptides, Vol. 21, Núm. 2, pp. 265-269